Six Go-To-Market Blind Spots Holding Seed and Series A Digital Health Companies Back

Digital health startups between $2M and $15M in revenue often stall because their go-to-market has a sales architecture problem, not a talent problem. The six blind spots are: relying on the product to sell, running one playbook across different buyer segments, underusing customer success insight, hiring ahead of a defined buyer journey, spending new capital on headcount before building the architecture, and selling to a health system as if it were a single buyer.

Many investor-backed digital health startups hit a similar wall.

The product launches, early customers sign on, and product-market fit is established. Sometimes early sales may even seem easy as they are founder-led and often relationship-driven. 

It’s the next stage where the challenges often arise. Somewhere between $2M and $15M in revenue, the market demands more to scale and secure a spot as a category leader. The go-to-market strategy that was scrappy and effective at the beginning is starting to show some cracks. If the impact isn’t showing yet, it’s often merely a matter of time.

Pipeline stalls, quota attainment slips, and someone suggests another BDR. The cause is more often structural: the team is selling without segmentation, an ideal client profile, or a playbook beyond what the founder carried in their head.

Sales architecture includes segmentation, ideal client profiles, buyer journey maps, and playbooks that let a sales team scale beyond founder-led selling.

Here are six places we consistently see it show up:

1. The product is doing the selling and it can’t anymore

Early on, it's tempting to let the product carry the GTM. Put it in front of the right buyer, let them see the value, close the deal. It works until the market catches up and every competitor has a comparable product.

At that point, the sales organization itself has to become the advantage. This includes the playbooks, the org structure, the discipline of a real sales practice. Once competitors ship comparable products, the demo stops differentiating. The sales process has to.

2. One playbook, multiple market motions

Enterprise health systems, single hospitals, post-acute care, mid-market clinics, and individual practices don't buy the same way. But most growth-stage sales teams are running it all through a single, undifferentiated process — no segment-specific qualification, no tailored demo flows, no proof points built for the buyer in front of them.

We worked with a digital health company that found nine segments for a single product, from K-12 programs to medical schools. K-12 purchasing ran through grants and district boards. Medical schools bought through deans and capital committees. Same product, different buyer, different procurement process, different reason to buy.

If the company is lucky, a top performer has quietly built their own version of what's needed. But a top performer's private version of the playbook leaves when that person does.

3. Customer success knows more than sales is using

Implementation teams, trainers, and customer advisory boards sit closer to the real buyer's journey than almost anyone else in the company. They see what actually drives adoption, what objections resurface post-sale, and what success means to different segments.

Most companies have not connected that insight back to the sales motion. Customer success can do more strategic work in partnership with sales than it's currently being asked to do. The companies that make that connection tap into a valuable research function that already exists within their organization.

4. Every new hire is a missed structural decision

A familiar pattern emerges: revenue growth slows, so the answer is another BDR. But hiring ahead of a segmented buyer's journey means making structural decisions on instinct, not by design.

Once market segmentation and sales best practices are actually documented, hiring stops being a guess. It becomes a decision informed by where the gaps really are and where fit can be determined more accurately.

5. New capital goes to headcount before architecture

It's a hard trade to make on purpose. New funding creates real pressure to move fast and show traction. Headcount feels like the fastest lever. But few Seed and Series A companies invest in their GTM architecture ahead of or alongside that hiring.

Using growth capital to accelerate short-term traction is the right call. Using some of it to also build a deliberate GTM plan and engine is what makes the next round of hiring most effective.

6. Enterprise selling requires an enterprise strategy 

Most companies or sales reps focus on a single leader, department, or facility. Larger healthcare providers and payers rarely buy that way. Winning within a health system means engaging the entire leadership team and the organization while understanding the steps in their specific buyer's journey. It's not enough to court the champion who signed off first. 

That extends to territory design. Multi-facility, multi-stakeholder enterprises need to be treated as a single unit, not carved up by rep convenience. It's an easy structural fix that most companies overlook, and it eliminates both internal and client-facing confusion.

What is the pattern underneath these common GTM blind spots?

Each of these shows up once a company outgrows the sales motion that got it to its first few million in revenue. They're architecture problems — the kind that don't show up until a company outgrows the sales motion that worked for a time.

This is buildable GTM work. Segmentation, ideal client profiles, buyer journey maps, and playbooks are the foundation of the second growth curve, and they pay off most when built before the next hire. They're the foundation of the second growth curve, and they're most valuable when they're built before the next hire, not after.

The companies that break through do something different. They intentionally transform, rebuilding how the organization works so it can on-ramp to a second, steeper growth curve instead of riding a previous one to a plateau.

What does your proactive refinement plan look like for the coming year?

Talk through your growth curve with our team. No deckware, simply meaningful conversation oriented to what's truly useful for you.

About Empactful Partners

Empactful Partners works alongside healthcare systems, emerging companies, and investors wanting to grow in a fundamentally different way. We embed inside your organization to build strategic advantages from within, developing the internal readiness, product innovation, and leadership capacity needed to accelerate through critical transitions and launch new growth curves. Unlike traditional consulting, we don't build deckware. We help you build the human and structural layers that enable you to own your growth.